Skip to main content


Page 3 of 70

  1. Definitive radiotherapy plus concurrent chemotherapy has been a standard treatment for esophagus patients who are unfit to undergo surgery. However, there are a variety of concurrent chemotherapy regimens with...

    Authors: Hui Jiang, Kanjiebubi Makelike, Baoqing Chen, Mian Xi, Qiaoqiao Li, Yonghong Hu and Yujia Zhu
    Citation: Radiation Oncology 2023 18:150
  2. This study aims to validate the effectiveness of linear regression for motion prediction of internal organs or tumors on 2D cine-MR and to present an online gating signal prediction scheme that can improve the...

    Authors: Yang Li, Zhenjiang Li, Jian Zhu, Baosheng Li, Huazhong Shu and Di Ge
    Citation: Radiation Oncology 2023 18:149
  3. Target volume definition for curative radiochemotherapy in head and neck cancer is crucial since the predominant recurrence pattern is local. Additional diagnostic imaging like MRI is increasingly used, yet it...

    Authors: Kerstin Clasen, Marcel Nachbar, Sergios Gatidis, Daniel Zips, Daniela Thorwarth and Stefan Welz
    Citation: Radiation Oncology 2023 18:148
  4. Volumetric modulated arc therapy (VMAT) for locally advanced rectal cancer (LARC) has emerged as a promising technique, but the planning process can be time-consuming and dependent on planner expertise. We aim...

    Authors: Kouta Hirotaki, Kento Tomizawa, Shunsuke Moriya, Hajime Oyoshi, Vijay Raturi, Masashi Ito and Takeji Sakae
    Citation: Radiation Oncology 2023 18:147
  5. The interest in MR-only workflows is growing with the introduction of artificial intelligence in the synthetic CT generators converting MR images into CT images. The aim of this study was to evaluate several c...

    Authors: Damien Autret, Camille Guillerminet, Alban Roussel, Erwan Cossec-Kerloc’h and Stéphane Dufreneix
    Citation: Radiation Oncology 2023 18:146
  6. Adaptive radiotherapy (ART) was introduced in the late 1990s to improve the accuracy and efficiency of therapy and minimize radiation-induced toxicities. ART combines multiple tools for imaging, assessing the ...

    Authors: Hefei Liu, David Schaal, Heather Curry, Ryan Clark, Anthony Magliari, Patrick Kupelian, Deepak Khuntia and Sushil Beriwal
    Citation: Radiation Oncology 2023 18:144
  7. We conducted a retrospective statistical analysis of clinical and physical dosimetric factors of lung cancer patients who had previously undergone lung and/or mediastinal radiotherapy and died of or survived s...

    Authors: Jing Zhao, Chenying Ma, Guanghui Gan, Xiaoting Xu and Juying Zhou
    Citation: Radiation Oncology 2023 18:143
  8. Definitive concurrent chemoradiotherapy (dCCRT) is suggested as the standard treatment for cervical esophageal squamous cell carcinoma (CESCC). This retrospective propensity study compared the 8-year survival ...

    Authors: Jianing Wang, Yajing Wu, Wei Zhang, Yujia Chen, Qing Liu, Shaowu Jing, Jiandong Zhang, Fengpeng Wu, Jun Wang and Xueying Qiao
    Citation: Radiation Oncology 2023 18:142
  9. Hypothyroidism (HT) and subclinical HT after radiotherapy is frequent in nasopharyngeal carcinoma (NPC) patients, results in negative impact on patients' quality of life. The percentage of thyroid volume recei...

    Authors: Yun Xu, Hewei Peng, Guangjian Su, Yanming Cheng, Qiaojuan Guo, Lanyan Guo, Xian-E Peng and Jiangfeng Ke
    Citation: Radiation Oncology 2023 18:141
  10. In this study, we evaluated the efficacy and toxicity of stereotactic body radiotherapy (SBRT) as replacement strategy of conventionally fractionated radiation therapy in stage III non-small cell lung cancer (...

    Authors: Zhen Jia, Fang Fang, Yangsen Cao, Xiaofei Zhu, XiaoYu Yang, Xueling Guo and Huojun Zhang
    Citation: Radiation Oncology 2023 18:140

    The Correction to this article has been published in Radiation Oncology 2023 18:169

  11. Authors: Ayaka Ogawa, Michio Yoshimura, Mitsuhiro Nakamura, Takanori Adachi, Takahiro Iwai, Ryo Ashida and Takashi Mizowaki
    Citation: Radiation Oncology 2023 18:139

    The original article was published in Radiation Oncology 2023 18:103

  12. Intensity-modulated radiotherapy is developed as a replacement for 3-dimensional conformal radiation therapy. Considering the difference in costs and effectiveness of these interventions, the aim of this study...

    Authors: Mehdi Varmaghani, Malihe Amiri, Hossein Ebrahimpour, Roham Salek and Javad Javan-Noughabi
    Citation: Radiation Oncology 2023 18:138
  13. Magnetic resonance-guided adaptive radiotherapy (MRgART) treatment sessions at MR-Linac are time-consuming and changes in organs at risk volumes can impact the treatment dosimetry. This study aims to evaluate ...

    Authors: Xi Feng, Bin Tang, Xinghong Yao, Min Liu, Xiongfei Liao, Ke Yuan, Qian Peng and Lucia Clara Orlandini
    Citation: Radiation Oncology 2023 18:136
  14. Magnetic resonance imaging guided radiotherapy (MRgRT) offers treatment plan adaptation to the anatomy of the day. In the current MRgRT workflow, this requires the time consuming and repetitive task of manual ...

    Authors: Marvin F. Ribeiro, Sebastian Marschner, Maria Kawula, Moritz Rabe, Stefanie Corradini, Claus Belka, Marco Riboldi, Guillaume Landry and Christopher Kurz
    Citation: Radiation Oncology 2023 18:135
  15. We evaluated the prevalence and identified the risk factors for retropharyngeal and retro-styloid lymph node metastasis (LNM) in patients with hypopharyngeal carcinoma (HPC). This was achieved using a combinat...

    Authors: Ryo Toya, Tomohiko Matsuyama, Tetsuo Saito, Yoshiyuki Fukugawa, Takahiro Watakabe, Shinya Shiraishi, Daizo Murakami, Yorihisa Orita, Toshinori Hirai and Natsuo Oya
    Citation: Radiation Oncology 2023 18:134
  16. With advances in understanding liver tolerance, conformal techniques, image guidance, and motion management, dose-escalated radiotherapy has become a potential treatment for inoperable hepatocellular carcinoma...

    Authors: Uri Amit, Jahan J Mohiuddin, Andrzej P Wojcieszynski, Joanna Harton, Graeme Williams, Shwetha Manjunath, Nikhil Grandhi, Abigail Doucette, John P Plastaras, James M Metz and Edgar Ben-Josef
    Citation: Radiation Oncology 2023 18:133
  17. Children with brain tumors are at high risk of neurocognitive decline after radiotherapy (RT). However, there is a lack of studies on how RT doses to organs at risk (OARs) impacts neurocognition. The aim of th...

    Authors: Helena Söderström, Angelica Walfridsson, Ulla Martinsson, Ulf Isacsson, Karin Brocki, Johan Lundin Kleberg and Gustaf Ljungman
    Citation: Radiation Oncology 2023 18:132
  18. Long-term outcomes and prognostic factors of proton radiotherapy for locally advanced pancreatic cancer (LAPC) in the body and tail are still unknown. The aim of this study was to determine the prognostic fact...

    Authors: Katsuya Ami, Kazuki Terashima, Jun Ishida, Masaki Suga, Taisuke Okawa, Daiki Takahashi, SungChul Park, Yoshiro Matsuo, Yoshihide Nanno, Sunao Tokumaru, Tomoaki Okimoto, Hirochika Toyama and Takumi Fukumoto
    Citation: Radiation Oncology 2023 18:131
  19. Although radiotherapy after breast-conserving surgery has been the standard treatment for breast cancer, some people still refuse to undergo radiotherapy. The aim of this study is to identify risk factors for ...

    Authors: Jiameng Liu, Zhanlin Zhu, Zhipeng Hua, Weijie Lin, Yiyin Weng, Juli Lin, Hehui Mao, Lifen Lin, Xuming Chen and Jujiang Guo
    Citation: Radiation Oncology 2023 18:130
  20. In this study, we aimed to compare the radiation-induced hepatic toxicity (RIHT) outcomes of radiotherapy (RT) plus antibodies against programmed cell death protein 1 (anti-PD1) versus RT alone in patients wit...

    Authors: Rui-Jun Zhang, Hong-Mei Zhou, Hai-Yan Lu, Hong-Ping Yu, Wei-Zhong Tang, Mo-Qin Qiu, Liu-Ying Yan, Mei-Ying Long, Ting-Shi Su, Bang-De Xiang, Mei-Ling He, Xiao-Ting Wang, Shi-Xiong Liang and Jian-Xu Li
    Citation: Radiation Oncology 2023 18:129
  21. The management of ultracentral thoracic tumors with ablative dose of radiotherapy remains challenging given proximity to critical central structures. We report patient outcomes, toxicity, and dosimetry for ult...

    Authors: Crosby Rock, Sumit Sood, Ying Cao, Shary Shelton, Ronald C. Chen and Fen Wang
    Citation: Radiation Oncology 2023 18:128
  22. Oligometastatic disease in prostate cancer (PCa) is a challenging clinical scenario encountered more frequently with the widespread adoption of PSMA-PET. SBRT aims to defer androgen deprivation and may deliver...

    Authors: Riche Mohan, A. Kneebone, T. Eade, E. Hsiao, L. Emmett, Christopher Brown, J. Hunter and G. Hruby
    Citation: Radiation Oncology 2023 18:127
  23. Beam matching is a concept in radiotherapy applied to clinics where more than one linac is employed to harmonise beam characteristics across linacs for allowing patients interchange without replanning. In view...

    Authors: Diana M. Ghemiș, Loredana G. Marcu, Vasile Virag and Adriana Virag
    Citation: Radiation Oncology 2023 18:126
  24. Prognostic biomarkers identifying patients with early tumor progression after local ablative therapy remain an unmet clinical need. The aim of this study was to investigate circulating miR-21 and miR-210 level...

    Authors: Matthias Stechele, Henrike Link, Heidrun Hirner-Eppeneder, Marianna Alunni-Fabbroni, Moritz Wildgruber, Lukas Salvermoser, Stefanie Corradini, Regina Schinner, Najib Ben Khaled, Daniel Rössler, Eithan Galun, Shraga Nahum Goldberg, Jens Ricke and Philipp Maximilian Kazmierczak
    Citation: Radiation Oncology 2023 18:125
  25. Breast radiotherapy (RT) induces diffuse myocardial changes, which may increase the incidence of heart failure with preserved ejection fraction. This study aimed to evaluate the early signs of diffuse fibrosis...

    Authors: Mikko Moisander, Tanja Skyttä, Sari Kivistö, Heini Huhtala, Kjell Nikus, Vesa Virtanen, Pirkko-Liisa Kellokumpu-Lehtinen, Pekka Raatikainen and Suvi Tuohinen
    Citation: Radiation Oncology 2023 18:124
  26. Intra-operative radiation therapy (IORT) is a newer partial breast irradiation technique that has been well studied in 2 large randomized trials, the TARGIT-A and ELIOT trials. We initiated our IORT program in...

    Authors: Therese Youssef Andraos, Karin A. Skalina, Sheldon Feldman, Keyur Mehta, Wolfgang A. Tome, Maureen P. McEvoy, Anjuli M. Gupta and Jana L. Fox
    Citation: Radiation Oncology 2023 18:123
  27. With remarkable success and few side effects, induction chemoimmunotherapy has been used to improve the prognosis of patients with resectable or potentially resectable non-small cell lung cancer (NSCLC), even ...

    Authors: Song Guan, Kai Ren, Xuyu Zhang, Meng Yan, Xue Li and Lujun Zhao
    Citation: Radiation Oncology 2023 18:122
  28. Radiation-induced oral mucositis (RIOM), is a common, debilitating, acute side effect of radiotherapy for oral cavity (OC) and oropharyngeal (OPx) cancers; technical innovations for reducing it are seldom disc...

    Authors: Sapna Nangia, Utpal Gaikwad, M. P. Noufal, Mayur Sawant, Manoj Wakde, Ashwathy Mathew, Srinivas Chilukuri, Dayananda Sharma and Rakesh Jalali
    Citation: Radiation Oncology 2023 18:121
  29. The purpose of this study was to evaluate the efficacy of postoperative adjuvant radiotherapy for patients with upper tract urothelial carcinoma (UTUC) who underwent kidney-sparing surgery (KSS).

    Authors: Hui Guan, Guangyu Wang, Weiping Wang, Yuncan Zhou, Zhikai Liu, Xiaorong Hou, Junfang Yan, Shuai Sun, Ke Hu and Jing Zhao
    Citation: Radiation Oncology 2023 18:120
  30. For accurate thoracic and abdominal radiotherapy, inter- and intrafractional geometrical uncertainties need to be considered to enable accurate margin sizes. We aim to quantify interfractional diaphragm and ab...

    Authors: Karin M. Meijer, Irma W. E. M. van Dijk, Marije Frank, Arnout D. van den Hoek, Brian V. Balgobind, Geert O. Janssens, Markus Wendling, John H. Maduro, Abigail Bryce-Atkinson, Anna Loginova and Arjan Bel
    Citation: Radiation Oncology 2023 18:119
  31. To investigate the feasibility and performance of deep learning (DL) models combined with plan complexity (PC) and dosiomics features in the patient-specific quality assurance (PSQA) for patients underwent vol...

    Authors: Ce Han, Ji Zhang, Bing Yu, Haoze Zheng, Yibo Wu, Zhixi Lin, Boda Ning, Jinling Yi, Congying Xie and Xiance Jin
    Citation: Radiation Oncology 2023 18:116
  32. Ninety percent of patients receiving radiation therapy experience side effects. Busy schedules and intensive health education programs may lead to incomplete education content delivery and inaccurate patient s...

    Authors: Huei-Fan Yang, Wen-Wei Chang, Ying-Hsiang Chou, Jing-Yang Huang, Ya-Fang Ke, Pei-Fang Tsai, Hsiu-Man Chan, Hsueh-Ya Tsai, Hsien-Chun Tseng, Shih-Tsung Chang and Yueh-Chun Lee
    Citation: Radiation Oncology 2023 18:115
  33. Local primary-recurrence of esophageal squamous cell carcinoma (ESCC) after definitive treatment has the potential for increasing overall survival with re-irradiation (Re-RT), especially with advanced techniqu...

    Authors: Geng Xiang, Chunsheng Xu, Guangjin Chai, Bo Lyu, Zhaohui Li, Bin Wang, Mei Shi and Lina Zhao
    Citation: Radiation Oncology 2023 18:114
  34. Radiotherapy is, with surgery, one of the main therapeutic treatment strategies for meningiomas. No prospective study has defined a consensus for the delineation of target volumes for meningioma radiotherapy. ...

    Authors: Nicolas Martz, Julia Salleron, Frédéric Dhermain, Guillaume Vogin, Jean-François Daisne, Raphaelle Mouttet-Audouard, Ronan Tanguy, Georges Noel, Matthieu Peyre, Isabelle Lecouillard, Julian Jacob, Justine Attal, Marie Charissoux, Ovidiu Veresezan, Chantal Hanzen, Aymeri Huchet…
    Citation: Radiation Oncology 2023 18:113
  35. Surface-guided radiotherapy (SGRT) has been demonstrated to be a promising supplement to cone-beam computed tomography (CBCT) in adjuvant breast cancer radiotherapy, but a rational combination mode is lacking ...

    Authors: Haiyan Peng, Han Yang, Jinyan Lei, Xinyao Dai, Panpan Cao, Fu Jin and Huanli Luo
    Citation: Radiation Oncology 2023 18:112
  36. The CREST study showed that the addition of thoracic radiotherapy (TRT) could improve the survival rate in patients with extensive stage small cell lung cancer (ES-SCLC), but whether TRT can bring survival ben...

    Authors: Jianfeng Peng, Lemeng Zhang, Liping Wang, Hui Feng, Dongmei Yao, Rui Meng, Xiaomei Liu, Xiaohua Li, Ningbo Liu, Bingxu Tan, Zhaoqin Huang, Shanshan Li and Xiangjiao Meng
    Citation: Radiation Oncology 2023 18:111
  37. Current intensity-modulated radiation therapy (IMRT) treatment planning is still a manual and time/resource consuming task, knowledge-based planning methods with appropriate predictions have been shown to enha...

    Authors: Yongbao Li, Wenwen Cai, Fan Xiao, Xuanru Zhou, Jiajun Cai, Linghong Zhou, Wen Dou and Ting Song
    Citation: Radiation Oncology 2023 18:110
  38. Programmed cell death-1 (PD-1) inhibitor was proven to be useful for the recurrent/metastatic head and neck squamous carcinoma (R/M HNSCC) patients. Though both PD-1 inhibitor alone and combination with chemot...

    Authors: Lu Li, Lu Chen, Lu Yan, Yueqian Guo, Fang Li, Ming Fan, Mei Lan, Xin Lai, Jie Zhou, Yecai Huang, Peng Xu, Jinyi Lang and Mei Feng
    Citation: Radiation Oncology 2023 18:109
  39. This study was to improve image quality for high-speed MR imaging using a deep learning method for online adaptive radiotherapy in prostate cancer. We then evaluated its benefits on image registration.

    Authors: Ji Zhu, Xinyuan Chen, Yuxiang Liu, Bining Yang, Ran Wei, Shirui Qin, Zhuanbo Yang, Zhihui Hu, Jianrong Dai and Kuo Men
    Citation: Radiation Oncology 2023 18:108
  40. Breast cancer brain metastases (BCBM) are highly heterogenous with widely differing survival. The prognosis of the oligometastatic breast cancer (BC) patients with brain metastases (BM) has not been well studi...

    Authors: Wei Shi, Yang Li, Hua Sun, Li Zhang, Jin Meng, Xiaofang Wang, Xingxing Chen, Xiaomeng Zhang, Xin Mei, Jinli Ma, Miao Mo, Changming Zhou, Fei Liang, Zhimin Shao, Zhen Zhang, Xiaomao Guo…
    Citation: Radiation Oncology 2023 18:107
  41. To evaluate proton beam therapy (PBT) in multimodal treatment for locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus (NPSCC).

    Authors: Takashi Saito, Masahiro Nakayama, Kayoko Ohnishi, Shuho Tanaka, Masatoshi Nakamura, Motohiro Murakami, Shin Matsumoto, Keiichiro Baba, Keitaro Fujii, Masashi Mizumoto, Keiji Tabuchi and Hideyuki Sakurai
    Citation: Radiation Oncology 2023 18:106
  42. This study compares the dosimetric plans of three distinct boost modalities in cervical cancer (CC): intracavitary (IC) with tandem/ovoids brachytherapy (BT), IC + interstitial (IS) BT, and Stereotactic-Body-R...

    Authors: Sofian Benkhaled, Kadiatou Diakité, Nicolas Jullian, Sara Poeta, Christophe Vandekerkhove, Paul Van Houtte, Dirk Van Gestel and Alex De Caluwé
    Citation: Radiation Oncology 2023 18:105
  43. We aimed to evaluate the optimal management for elderly patients with nasopharyngeal carcinoma (NPC) with intensity-modulated radiotherapy (IMRT).

    Authors: Ying Li, Youliang Weng, Zongwei Huang, Yuhui Pan, Sunqin Cai, Qin Ding, Zijie Wu, Xin Chen, Jun Lu, Dan Hu and Sufang Qiu
    Citation: Radiation Oncology 2023 18:104
  44. This study examined the differences in late gastrointestinal (GI) toxicities in moderately hypofractionated intensity-modulated radiation therapy (IMRT) for locally advanced pancreatic ductal adenocarcinoma (L...

    Authors: Ayaka Ogawa, Michio Yoshimura, Mitsuhiro Nakamura, Takanori Adachi, Takahiro Iwai, Ryo Ashida and Takashi Mizowaki
    Citation: Radiation Oncology 2023 18:103

    The Correction to this article has been published in Radiation Oncology 2023 18:139

  45. This study aims to explore the advantages and robustness of the partial arc combined with prone position planning technique for radiotherapy in rectal cancer patients. Adaptive radiotherapy is recalculated and...

    Authors: Zhe Zhang, Shou Yu, Feng Peng, Zhibo Tan, Lei Zhang, Daming Li, Pengfei Yang, Zhaoming Peng, Xin Li, Chunfeng Fang, Yuenan Wang and Yajie Liu
    Citation: Radiation Oncology 2023 18:102
  46. Patients with hepatocellular carcinoma (HCC) involving portal vein tumor thrombosis (PVTT) are presently lacking effective treatment options. We aimed to compare the efficacy and safety of lenvatinib with or w...

    Authors: Xiaoquan Ji, Zhe Xu, Jing Sun, Wengang Li, Xuezhang Duan and Quan Wang
    Citation: Radiation Oncology 2023 18:101

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    605 Altmetric mentions